Ribavirin (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the Ribavirin drug offered from Cadila Healthcare Limited. This Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
NON-PROPRIETARY NAME: | Ribavirin |
SUBSTANCE NAME: | RIBAVIRIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2006-01-25 |
END MARKETING DATE: | 0000-00-00 |
Ribavirin HUMAN PRESCRIPTION DRUG Details:
Item Description | Ribavirin from Cadila Healthcare Limited |
LABELER NAME: | Cadila Healthcare Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 2006-01-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65841-260_12a35e7b-2e56-4b65-9a59-6f19b90b5d7e |
PRODUCT NDC: | 65841-260 |
APPLICATION NUMBER: | ANDA077224 |
Other RIBAVIRIN Pharmaceutical Manufacturers / Labelers: